SEER Seer Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SEER

Price (delayed)

$1.85

Market cap

$101.72M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.24

Enterprise value

$76.9M

?
Relative Growth: Rel. Growth: 29
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 26

Seek Inc. is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that ...

Highlights
The net income is up by 18% year-on-year and by 4.2% since the previous quarter
Seer's EPS has increased by 12% YoY and by 3.1% from the previous quarter
Seer's quick ratio has increased by 37% QoQ but it has decreased by 10% YoY
SEER's equity is down by 22% year-on-year and by 7% since the previous quarter
SEER's gross profit is down by 13% from the previous quarter and by 4.8% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://seer.bio
Peers: RVTY QTRX PRPO MTD

Key stats

What are the main financial stats of SEER

SEER stock price

How has the Seer stock price performed over time
Intraday
-0.54%
1 week
-4.15%
1 month
-5.13%
1 year
-15.53%
YTD
1.09%
QTD
10.12%

Financial performance

How have Seer's revenue and profit performed over time
Revenue
$15.17M
Gross profit
$7.39M
Operating income
-$74.52M
Net income
-$70.49M
Gross margin
48.7%
Net margin
-464.8%
Seer's operating income has increased by 22% YoY and by 4.5% from the previous quarter
Seer's operating margin has increased by 21% YoY but it has decreased by 4.4% QoQ
The net income is up by 18% year-on-year and by 4.2% since the previous quarter
The net margin has increased by 17% YoY but it has decreased by 4.7% from the previous quarter

Price vs fundamentals

How does SEER's price correlate with its fundamentals

Growth

What is Seer's growth rate over time

Valuation

What is Seer stock price valuation
P/E
N/A
P/B
0.43
P/S
6.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.07
Seer's EPS has increased by 12% YoY and by 3.1% from the previous quarter
The stock's price to book (P/B) is 61% less than its 5-year quarterly average of 1.1 but 8% more than its last 4 quarters average of 0.4
SEER's equity is down by 22% year-on-year and by 7% since the previous quarter
SEER's P/S is 94% below its 5-year quarterly average of 108.7
The revenue has decreased by 9% QoQ

Efficiency

How efficient is Seer business performance
Seer's ROS has increased by 17% YoY but it has decreased by 4.8% from the previous quarter
SEER's return on invested capital is down by 7% year-on-year and by 2.3% since the previous quarter
The company's return on equity fell by 4.3% YoY and by 2.3% QoQ
SEER's return on assets is down by 3.1% year-on-year

Dividends

What is SEER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SEER.

Financial health

How did Seer financials performed over time
Seer's current ratio has increased by 38% from the previous quarter but it has decreased by 8% YoY
Seer's quick ratio has increased by 37% QoQ but it has decreased by 10% YoY
The debt is 90% less than the equity
SEER's debt to equity is up by 25% year-on-year and by 11% since the previous quarter
SEER's equity is down by 22% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.